• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: a jump with a weak parachute?

作者信息

Galli Mattia, Andreotti Felicita, Savarese Gianluigi, D'Amario Domenico, Vergallo Rocco, Della Bona Roberta, Calò Leonardo, Porto Italo, Crea Filippo

机构信息

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, Rome, Italy.

Division of Cardiology, Department of Medicine, Karolinska Institutet, Solnavägen 1, Solna, Sweden.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):55-56. doi: 10.1093/ehjcvp/pvy039.

DOI:10.1093/ehjcvp/pvy039
PMID:30289484
Abstract
摘要

相似文献

1
Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: a jump with a weak parachute?在接受经皮冠状动脉介入治疗的心房颤动患者中停用阿司匹林：这是一次配备薄弱降落伞的跳跃吗？
Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):55-56. doi: 10.1093/ehjcvp/pvy039.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
3
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?非瓣膜性心房颤动患者行经皮冠状动脉介入治疗中的抗血栓治疗：在 PIONEER AF-PCI 和 RE-DUAL PCI 试验之后，我们是否应该改变我们的治疗实践？
Clin Res Cardiol. 2018 Jul;107(7):533-538. doi: 10.1007/s00392-018-1242-2. Epub 2018 Apr 20.
4
From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.从治疗方案的选择到治疗强度的选择：接受经皮冠状动脉介入治疗的房颤患者抗栓治疗观念的转变
Cardiovasc Drugs Ther. 2020 Feb;34(1):143-144. doi: 10.1007/s10557-019-06903-y.
5
Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.经皮冠状动脉介入治疗的非瓣膜性心房颤动患者的当代抗栓治疗：希腊抗血小板心房颤动（GRAPE-AF）注册研究的原理和设计。
Cardiovasc Drugs Ther. 2018 Apr;32(2):191-196. doi: 10.1007/s10557-018-6789-7.
6
Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.急性冠状动脉综合征或经皮冠状动脉介入治疗后房颤患者的双联与三联抗栓治疗：一项更新的荟萃分析
Cardiovasc Revasc Med. 2020 Feb;21(2):239-241. doi: 10.1016/j.carrev.2019.08.015. Epub 2019 Aug 20.
7
Safety and Efficacy of Oral Anticoagulants Therapies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-Analysis.口服抗凝药物治疗在经皮冠状动脉介入治疗的心房颤动患者中的安全性和疗效：一项网状荟萃分析。
J Cardiovasc Pharmacol Ther. 2020 Sep;25(5):399-408. doi: 10.1177/1074248420930136. Epub 2020 Jun 3.
8
Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.经皮冠状动脉介入治疗后三联抗栓治疗的出血并发症
Catheter Cardiovasc Interv. 2017 Feb 1;89(2):E64-E74. doi: 10.1002/ccd.26574. Epub 2016 May 24.
9
Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations.接受经皮冠状动脉介入治疗的心房颤动患者抗血栓治疗管理算法：基于疗效考量的更新建议
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):197-198. doi: 10.1093/ehjcvp/pvaa003.
10
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine.急性 B 型主动脉夹层的抗凝和抗血栓治疗：当现实情况面临循证医学的阴影时。
BMC Cardiovasc Disord. 2020 Jan 23;20(1):29. doi: 10.1186/s12872-020-01342-2.

引用本文的文献

1
Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者从维生素K拮抗剂转换为非维生素K拮抗剂的诸多充分理由。
J Clin Med. 2021 Jun 28;10(13):2866. doi: 10.3390/jcm10132866.
2
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal.心房颤动合并急性冠状动脉综合征/经皮冠状动脉介入治疗中双联与三联抗栓治疗的随机试验和荟萃分析：一项批判性评估。
Int J Cardiol Heart Vasc. 2020 May 14;28:100524. doi: 10.1016/j.ijcha.2020.100524. eCollection 2020 Jun.